CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 32 filers reported holding CARDIOME PHARMA CORP in Q2 2016. The put-call ratio across all filers is 8.80 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlphaOne Investment Services, LLC | 531,493 | $5,002,000 | 1.76% |
| TURNER INVESTMENTS LLC | 503,222 | $4,735,000 | 0.87% |
| Rock Springs Capital Management LP | 625,000 | $5,881,000 | 0.43% |
| CLOUGH CAPITAL PARTNERS L P | 787,583 | $7,411,000 | 0.28% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,753,510 | $25,911,000 | 0.16% |
| PUTNAM INVESTMENTS LLC | 1,835,900 | $17,275,000 | 0.04% |
| PointState Capital LP | 312,437 | $2,940,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 23,400 | $220,000 | 0.03% |
| K2 PRINCIPAL FUND, L.P. | 13,579 | $128,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | $4,705,000 | 0.01% |